A total of 693 pharmaceutical and medical technology companies submitted their data related to the year 2022. Together, they invested a total of €268.768.800 in 2022 in collaborations with healthcare providers, healthcare institutions and patient associations active in Belgium.
Each year Mdeon draws up an activity report on betransparent. The report of 2020 is online.
Click here (French) or here (Dutch) to consult the annual report 2020.
The Belgian Official Journal published today the Royal Decree of 8 June 2021 which designates once again the non-profit association Mdeon to carry out the missions entrusted to the FAMHP by the Sunshine Act. In particular, Mdeon manages the unique publicly accessible website (www.betransparent.be) which discloses annually the premiums and benefits that pharmaceutical and medical devices companies grant to healthcare professionals/organisations and patient organizations.
The authorization granted to Mdeon is valid for a period of 4 years (1.1.2022 – 31.12.2026).
A total of 643 pharmaceutical and medical technology companies submitted their data for the year 2020. Together in 2020, they invested a total of 191.397.504 euros in collaborations with healthcare providers, healthcare institutions and patient associations active in Belgium.
For more results and the press release, click here (in Dutch) or here (in French).